Thermalin Diabetes' Grant - II Round

Thermalin Diabetes raised a round of funding on December 14, 2009. Investors include Innovation Fund America.

Thermalin is pursuing promising product profiles that will improve insulin therapy for specific classes of patients and enable new delivery technologies. These include: Ultra-concentrated (U500) insul…

Articles about Thermalin Diabetes' Grant - II Round: